Pulmatrix

Pulmatrix Shareholder Yield

Shareholder Yield of Pulmatrix (PULM) as of Oct 19, 2026.

Shareholder Yield

0.00

Last updated:

Shareholder Yield of Pulmatrix is 2025 0.00 . Shareholder Yield of Pulmatrix was 2024 0.00 . It decreases by % lower compared to the previous year.

The Pulmatrix Shareholder Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shareholder Yield
Date
Shareholder Yield
Jan 1, 2018
245.75 USD
Jan 1, 2019
225.47 USD
Jan 1, 2020
267.19 USD
Jan 1, 2021
40.71 USD
Jan 1, 2022
1.94 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The Pulmatrix Shareholder Yield history
YEARShareholder YieldYoY
0.00—
0.00—
0.00-100.00%
1.94 %-95.25%
40.71 %-84.76%
267.19 %+18.50%
225.47 %-8.25%
245.75 %+16.15%
211.58 %—
0.00-100.00%
129.27 %+1,073.53%
11.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulmatrix Stock analysis

What does Pulmatrix do? Pulmatrix Inc is a clinical stage biotechnology company based in Lexington, Massachusetts, focused on developing inhaled therapeutic products for respiratory and other diseases. The company went public via an IPO on March 21, 2014, and currently employs two full-time staff members. Pulmatrix utilizes its proprietary dry powder delivery technology, iSPERSE, to create inhaled therapies designed for local or systemic drug delivery to the lungs. The iSPERSE platform enables the formulation of small or large molecule drugs into dry powder form, engineered to be small, dense particles with optimal dispersibility and airway delivery. This technology is compatible with various dry powder inhaler devices and supports a wide range of drug substances, including small molecules and biologics. Pulmatrix has several therapeutic candidates in development, including Pulmazole, PUR1800, PUR5700, PUR3000, and PUR4000. The company's website is www.pulmatrix.com. Pulmatrix operates within the pharmaceuticals sector of the health care industry, targeting serious respiratory conditions through innovative inhaled drug delivery solutions. Pulmatrix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulmatrix stock

On Eulerpool you can find the complete historical development of Shareholder Yield Pulmatrix since 2006 – with annual values, charts, and detailed analysis.

Shareholder yield combines dividend yield and buyback yield to show the total cash return to shareholders. It captures both dividends and share repurchases.

To evaluate Shareholder Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Shareholder Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Shareholder Yield's Pulmatrix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pulmatrix

All Key Metrics — Pulmatrix